File(s) not publicly available
Reason: Data available on request subject to approval
Metadata record for the article: Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
Summary
This metadata record provides details of the data supporting the claims of the related article: “Evaluation of multiple transcriptomic gene risk signatures in male breast cancer”.
The related study presents the gene expression results of 381 M0, ER+ve, HER2-ve male male breast cancer (BCa) patients enrolled in the Part 1 (retrospective analysis) of the International Male Breast Cancer Program, as described in https://doi.org/10.1093/annonc/mdx651.
Type of data: survival analysis
Subject of data: Homo sapiens
Sample size: 381
Population characteristics: EORTC/TBCRC/BIG/NABCG International Male Breast Cancer Program enrolled male patients with histologically proven BCa, diagnosed between 1990 and 2010, across multiple participating institutions.
Data access
The data underlying the Kaplan Meier survival curves and tables that support the findings of this study are available from European Organisation for the Research and Treatment of Cancer (EORTC). However, the data are not publicly available and restrictions apply to their availability as they were used under license from EORTC for the current study. Data can be made available with the permission of EORTC. Data enquiries can be made to the corresponding author, and data requests can be made at https://www.eortc.org/data-sharing/.
Corresponding author(s) for this study
John M. S. Bartlett. Ontario Institute for Cancer Research, Diagnostic Development, MaRS Centre, 661 University Avenue, Suite 510, Toronto, ON M5G 0A3, Canada. 647-259-4251. John.Bartlett@oicr.on.ca
Study approval
Ethics approval was provided by the University of Toronto (#30035).